The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

NAActive, not recruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

January 4, 2024

Primary Completion Date

September 4, 2025

Study Completion Date

July 31, 2030

Conditions
Renal CancerTumor, SolidKidney CancerTumorTumor, Benign
Interventions
DEVICE

HistoSonics Edison System

Non-invasive destruction of kidney tissue using histotripsy, a non-thermal mechanical process of focused ultrasound.

Trial Locations (15)

10016

NYU Langone Health, New York

10029

Icahn School of Medicine Mount Sinai, New York

11042

Northwell Health, Lake Success

14642

University of Rochester Medical Center, Rochester

21287

Johns Hopkins University, Baltimore

34747

AdventHealth Celebration, Celebration

43212

The Ohio State University Comprehensive Cancer Center, Columbus

53705

University of Wisconsin School of Medicine and Public Health, Madison

75390

UT Southwestern Medical Center, Dallas

90089

University of Southern California, Los Angeles

90095

University of California, Los Angeles (UCLA), Los Angeles

92691

Providence Mission Hosptial, Mission Viejo

98122

Swedish Medical Center, Seattle

06510

Yale School of Medicine, New Haven

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

HistoSonics, Inc.

INDUSTRY